These new treatments inhibited IgE-mediated anaphylaxis in animal models (Table 3) and were tested in a Phase I trial conducted on allergic rhinitis patients (NCT01723254, Table 2); however their application in food allergy is still unclear. The gene discussed is IGHE; the disease is food allergy.